title: Revised recommendations for the prevention of secondary Haemophilus influenzae type b (Hib) disease.
authors.affiliation: Department of Paediatric Infectious Diseases, St George's Hospital, Blackshaw Road, Tooting, London SW17 0QT, UK.
authors.forename: Despoina
authors.initials: D
authors.lastname: Gkentzi
authors.forename: Sarah
authors.initials: S
authors.lastname: Collins
authors.forename: Mary E
authors.initials: ME
authors.lastname: Ramsay
authors.forename: Mary P E
authors.initials: MP
authors.lastname: Slack
authors.forename: Shamez
authors.initials: S
authors.lastname: Ladhani
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000900:Anti-Bacterial Agents / Q000008:administration & dosage; D019072:Antibiotic Prophylaxis / Q000379:methods*; D002648:Child; D002675:Child, Preschool; D006192:Haemophilus Infections / Q000188:drug therapy / Q000517:prevention & control* / Q000635:transmission; D018073:Haemophilus Vaccines / Q000008:administration & dosage*; D019741:Haemophilus influenzae type b; D006801:Humans; D007115:Immunization Schedule; D007223:Infant; D007231:Infant, Newborn; D008875:Middle Aged; D011634:Public Health; D012293:Rifampin / Q000008:administration & dosage; D006113:United Kingdom
chemical_list: D000900:Anti-Bacterial Agents; D018073:Haemophilus Vaccines; D012293:Rifampin